Regular Pap tests prevent cervical cancer by catching abnormal cells years before they ever become cancerous. Since widespread Pap screening began, cervical cancer incidence and mortality have dropped by 70% in countries that adopted it. The test works not by detecting cancer itself, but by finding precancerous changes early enough to remove them, effectively stopping the disease before it starts.
How a Pap Test Catches Cancer Early
During a Pap test, a clinician collects a small sample of cells from your cervix, specifically from an area called the transformation zone. This is the spot where the inner and outer parts of the cervix meet, and it’s where the vast majority of abnormal cell changes and cervical cancers originate. The collected cells are examined under a microscope for signs of abnormality.
What makes this approach so effective is that cervical cancer doesn’t appear overnight. It develops through a slow, predictable sequence. Normal cervical cells first develop mild abnormalities, then progress to moderate and severe changes, and only after years of unchecked progression do they become invasive cancer. A Pap test can identify cells at any point along that path. When abnormal cells are found early, they can be removed or destroyed before they ever turn malignant. These removal procedures cure cervical dysplasia in about 90% of cases.
What Your Results Mean
Pap results are categorized by how abnormal the cells look. A normal result means no unusual cells were found. Beyond that, results fall into a few key categories:
- ASC-US (atypical squamous cells of undetermined significance): mildly unusual cells that often resolve on their own. Your provider may recommend a follow-up test or HPV testing to determine whether further evaluation is needed.
- LSIL (low-grade squamous intraepithelial lesion): mild cell changes, often linked to an HPV infection. Many of these clear without treatment, but they warrant monitoring.
- HSIL (high-grade squamous intraepithelial lesion): moderate to severe cell changes that carry a real risk of progressing to cancer if left untreated. These typically require a procedure to remove the abnormal tissue.
The distinction between low-grade and high-grade matters because it determines how urgently your provider will act. Low-grade changes are common, especially in younger women, and frequently resolve as the immune system clears the underlying HPV infection. High-grade changes are the ones that screening is specifically designed to catch, because removing them at this stage is what prevents cancer from developing.
Why You Don’t Actually Need One Every Year
Despite the phrase “yearly Pap test” being ingrained in many people’s minds, current guidelines no longer recommend annual screening for most people. The U.S. Preventive Services Task Force recommends Pap tests every three years for women aged 21 to 29. For women aged 30 to 65, the options are a Pap test every three years, an HPV test every five years, or both tests together every five years. Screening is not recommended before age 21 or after age 65 for those with a history of adequate prior screening and no high-risk factors.
The shift away from annual testing happened because research showed that screening more frequently than every three years provides very little additional benefit while significantly increasing harms. Those harms include unnecessary biopsies, anxiety from false-positive results, and treatment of low-grade abnormalities that would have resolved on their own. Since cervical cancer develops slowly over many years, a three- to five-year interval gives plenty of time to catch changes before they become dangerous.
Pap Tests vs. HPV Tests
The Pap test looks at cells under a microscope for visible abnormalities. HPV testing, by contrast, checks for the presence of high-risk strains of the virus that cause nearly all cervical cancers. These are fundamentally different approaches, and they have different strengths.
HPV testing is significantly more sensitive. In a large study published in The Lancet Regional Health, HPV testing detected 98% of high-grade precancerous lesions, while Pap testing caught only about 49%. The Pap test, however, was more specific, meaning it produced fewer false positives (96.5% specificity versus 88.7% for HPV testing). Another important difference: Pap test accuracy varied dramatically depending on the lab and clinician performing it, with sensitivity ranging from 32% to 88% across different sites. HPV test results were far more consistent regardless of where the test was done.
This is why guidelines now allow HPV testing as a standalone screening option for women 30 and older. Because HPV testing catches precancerous changes at an earlier stage and does so more reliably, it also justifies longer intervals between screenings. Some women prefer the combined approach of both tests together for maximum reassurance, while others may opt for HPV-only screening every five years. All three strategies are considered equally acceptable by major medical organizations.
What Happens When Abnormal Cells Are Found
If your Pap test comes back abnormal, the next step is usually a closer look at your cervix through a procedure called colposcopy, where your provider examines the cervix with a magnifying instrument and may take a small tissue sample. This biopsy confirms the type and severity of the cell changes.
For mild abnormalities, the approach is often watchful waiting with repeat testing in 6 to 12 months. Many mild changes clear up without intervention. For moderate to severe changes, your provider will typically recommend removing or destroying the abnormal tissue. Several outpatient procedures can accomplish this, and they’re generally quick with short recovery times. The success rate is high: about 90% of cases are cured with a single treatment. After treatment, you’ll need more frequent follow-up screening for a period to make sure the abnormal cells haven’t returned.
This entire process, from detection of precancerous cells to their removal, is the core mechanism by which screening prevents cervical cancer. You’re not waiting for cancer to appear and then treating it. You’re eliminating the cells that would have become cancer years down the line.
Who Benefits Most From Screening
Cervical screening is most valuable for people who have a cervix and are between the ages of 21 and 65. Within that group, some people face higher risk and may need more frequent testing. Risk factors include a weakened immune system, a previous diagnosis of high-grade cervical changes, and exposure to the medication DES before birth.
HPV vaccination has dramatically reduced the prevalence of the virus strains responsible for most cervical cancers, but vaccinated individuals still need screening. The vaccine doesn’t cover every cancer-causing HPV strain, and screening remains the safety net that catches what vaccination misses. For people who were never vaccinated, screening is especially critical, as it’s the primary line of defense against a cancer that is almost entirely preventable when caught early.